The AstraZeneca vaccine has changed its name to Vaxzevria — the latest development amid intense public scrutiny. But Dr. Timothy Caulfield, a University of Alberta law professor and public health expert, says reports of blood clots is evidence the surveillance system is working and headlines around the story need to reflect vaccine effectiveness. .